{"meta":{"query_hash":"115b312e199a","filters":{"venue":"Therapeutic Advances in Rare Disease"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/115b312e199a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Rare+Disease"},"results":[{"id":"W4319996833","doi":"10.1177/26330040221150269","title":"Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Rare Diseases Clinical Research Network","keywords":"Internal medicine; Medicine; Phenocopy; Phosphoglucomutase; Gastroenterology; Hypoglycemia; Phenotype; Endocrinology; Biology; Biochemistry; Enzyme","score_opus":0.024203659665502635,"score_gpt":0.31134956671944003,"score_spread":0.2871459070539374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319996833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798114,0.004974181,0.0023296913,0.0006040909,0.00012202636,0.00007769245,0.000102968974,0.00008670336,0.003721489],"genre_scores_gemma":[0.99632543,0.0013555858,0.0008641225,0.00033741363,0.0001724506,0.000017193945,0.0000833872,0.000018414246,0.00082595507],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996947,0.000035335852,0.00004715634,0.00009026828,0.000050857525,0.00008167366],"domain_scores_gemma":[0.99959236,0.00008114932,0.00011079385,0.000044119868,0.000021199208,0.00015035737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016653746,0.0010201334,0.0006240657,0.0011171065,0.00084909913,0.00075773866,0.00049958145,0.0020350195,0.0011584824],"category_scores_gemma":[0.0010144254,0.0003466587,0.0006458213,0.00073084666,0.0008470264,0.00067698135,0.0007051505,0.0010637961,0.0005593627],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102205,0.00019551508,0.03866256,0.000079275145,0.0000359909,0.94339937,0.0004905934,0.0001962949,0.003574871,0.00023377337,0.00047551747,0.012554071],"study_design_scores_gemma":[0.000018703466,0.00013371259,0.013591765,0.000015856736,0.00003106121,0.98266834,0.00012853276,0.0003407173,0.0013419606,0.000117742406,0.0015965315,0.0000150456935],"about_ca_topic_score_codex":0.00077193184,"about_ca_topic_score_gemma":0.00089599885,"teacher_disagreement_score":0.0020350195,"about_ca_system_score_codex":0.00054739736,"about_ca_system_score_gemma":0.00025973906,"threshold_uncertainty_score":0.0039716363},"labels":[],"label_agreement":null},{"id":"W4385384941","doi":"10.1177/26330040231188979","title":"The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; Institut National de la Santé et de la Recherche Médicale; European Commission; Australian Government","keywords":"Task force; Task (project management); Investment (military); Disease; Public relations; Grant funding; Business; Psychology; Medicine; Political science; Marketing; Management; Economics; Pathology; Public administration","score_opus":0.03184840383005678,"score_gpt":0.4197062266891086,"score_spread":0.38785782285905185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385384941","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020936016,0.004943628,0.0072174533,0.89376456,0.011491089,0.006745455,0.0043061352,0.0005047542,0.05009092],"genre_scores_gemma":[0.21709386,0.013999595,0.09309371,0.49376538,0.020598713,0.04279147,0.017766938,0.0011334826,0.09975688],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8965643,0.047944978,0.0076154005,0.004030139,0.02682316,0.017022029],"domain_scores_gemma":[0.5517715,0.19400524,0.03695989,0.0123842135,0.10325764,0.10162143],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18405801,0.0015236288,0.0012080547,0.0035243595,0.012073334,0.010735877,0.0050069764,0.015351986,0.012357236],"category_scores_gemma":[0.18960443,0.0010824647,0.0014699313,0.0022176944,0.0048389,0.005059113,0.01775876,0.010361965,0.006692639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014546693,0.00021431147,0.005908789,0.0011642855,0.000024063043,0.00024767066,0.003520441,0.0003162887,0.0008919321,0.0075133974,0.9366551,0.043398224],"study_design_scores_gemma":[0.00021562411,0.00025707806,0.009718662,0.0027409869,0.000030038178,0.00024558813,0.008393773,0.0005026375,0.00044544335,0.004212463,0.97312397,0.000113554524],"about_ca_topic_score_codex":0.021101303,"about_ca_topic_score_gemma":0.02847692,"teacher_disagreement_score":0.815942,"about_ca_system_score_codex":0.011324683,"about_ca_system_score_gemma":0.09708322,"threshold_uncertainty_score":0.97340345},"labels":[],"label_agreement":null},{"id":"W4395453307","doi":"10.1177/26330040241245725","title":"Developing a pathway to clinical trials for <i>CACNA1A</i> -related epilepsies: A patient organization perspective","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Cleveland Clinic","keywords":"Perspective (graphical); Clinical trial; Epilepsy; Psychology; Medicine; Neuroscience; Computer science; Internal medicine; Artificial intelligence","score_opus":0.13595823645103633,"score_gpt":0.43832319553801186,"score_spread":0.3023649590869755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395453307","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046293666,0.121643946,0.012925057,0.7963262,0.011990077,0.0022830686,0.003604722,0.00068794994,0.045909554],"genre_scores_gemma":[0.07642361,0.22443151,0.086766236,0.51812685,0.052266408,0.011183904,0.007911603,0.00081430573,0.022075552],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.98960894,0.007221569,0.0010634467,0.00059950066,0.00075281266,0.0007537659],"domain_scores_gemma":[0.9631247,0.015151664,0.003722453,0.0011363666,0.007923403,0.008941414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01668572,0.00093305064,0.0022964082,0.001189847,0.0011973743,0.0070612137,0.0025890614,0.008090446,0.035718225],"category_scores_gemma":[0.03111359,0.00042068405,0.0031502303,0.001218108,0.001330396,0.0064058453,0.0050216573,0.008217166,0.011223258],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003913879,0.00080430985,0.0023727866,0.0052832533,0.0005802593,0.00076515676,0.00035736794,0.0009382382,0.0011286217,0.025487075,0.43820938,0.5201598],"study_design_scores_gemma":[0.008408564,0.002672765,0.0026646336,0.018547101,0.00088243687,0.0012504951,0.00054219476,0.0009029521,0.0005827578,0.05104671,0.9123756,0.00012373764],"about_ca_topic_score_codex":0.0011757206,"about_ca_topic_score_gemma":0.0032856443,"teacher_disagreement_score":0.035718225,"about_ca_system_score_codex":0.003342826,"about_ca_system_score_gemma":0.011763637,"threshold_uncertainty_score":0.11948937},"labels":[],"label_agreement":null},{"id":"W4398190827","doi":"10.1177/26330040241252448","title":"Understanding patient, caregiver, and healthcare provider perspectives of the management of long-chain fatty acid oxidation disorders","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"Ultragenyx Pharmaceutical","keywords":"Context (archaeology); Health care; Futures contract; Affect (linguistics); Medicine; Decompensation; Psychology; Nursing; Business; Internal medicine","score_opus":0.015649883581345586,"score_gpt":0.27970988985496026,"score_spread":0.2640600062736147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398190827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6571732,0.02582948,0.0043183384,0.26484007,0.0028366034,0.00017177417,0.00022512775,0.000079069745,0.044526324],"genre_scores_gemma":[0.9657291,0.010163727,0.0025142538,0.019561507,0.0004489637,0.00008441862,0.000079223224,0.000018858378,0.0013998968],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99276745,0.0046333103,0.00047887105,0.0003088778,0.0007905164,0.0010209921],"domain_scores_gemma":[0.99098283,0.0037628852,0.0013930086,0.00013175322,0.0012790868,0.0024504927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00669829,0.0004454513,0.0005703122,0.0007545574,0.006513208,0.0039708326,0.00086777844,0.002781909,0.0026215431],"category_scores_gemma":[0.020976018,0.00034941593,0.000700657,0.00061359024,0.0024294714,0.005357187,0.0044615655,0.004637523,0.0003055641],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013299093,0.00035497473,0.11725697,0.0008944385,0.00014309937,0.016928306,0.6912606,0.00046660015,0.0011651546,0.009177577,0.05169738,0.11052194],"study_design_scores_gemma":[0.00004217841,0.0002128463,0.029241692,0.0019585958,0.00008746548,0.0117881335,0.8725605,0.0007547309,0.00037412948,0.0051769624,0.0776524,0.00015039941],"about_ca_topic_score_codex":0.009535438,"about_ca_topic_score_gemma":0.022322336,"teacher_disagreement_score":0.009535438,"about_ca_system_score_codex":0.0036180087,"about_ca_system_score_gemma":0.0057438654,"threshold_uncertainty_score":0.03542441},"labels":[],"label_agreement":null},{"id":"W4401101806","doi":"10.1177/26330040241265414","title":"Koolen-de Vries Syndrome: a journey from diagnosis to treatments","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Natural history; Foundation (evidence); Translational research; Engineering ethics; Political science; Medicine; Psychology; Engineering; Pathology","score_opus":0.027493880096707987,"score_gpt":0.36227442663922244,"score_spread":0.33478054654251443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401101806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008115943,0.9977082,0.0000922393,0.0012365498,0.00025969456,0.0000022450763,0.000010617807,0.0000058354763,0.0006033976],"genre_scores_gemma":[0.0007228733,0.99784935,0.00019476032,0.00053988607,0.00027641188,0.000004550343,0.00002669597,0.0000020066498,0.000383412],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996973,0.00007130926,0.000048587804,0.000035112687,0.00011485076,0.000032819516],"domain_scores_gemma":[0.99936837,0.0003650649,0.00006434842,0.000014324785,0.00012948878,0.000058454905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010432528,0.00063515856,0.0011767218,0.0021549186,0.00041541556,0.0014394021,0.00091066066,0.001459442,0.0028022057],"category_scores_gemma":[0.0015401578,0.00023965945,0.0004939267,0.0016492028,0.0006496481,0.0016269208,0.0008298671,0.002898853,0.0013853777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009236112,0.00004437519,0.00021696184,0.011705933,0.000101131394,0.0005674665,0.00014097178,0.00033700035,0.00057220244,0.009048703,0.05809094,0.9190819],"study_design_scores_gemma":[0.000016007594,0.00005600216,0.00047029293,0.0071617616,0.000083954146,0.0026884782,0.00012814633,0.000073037176,0.00018469976,0.004302808,0.9848166,0.00001807878],"about_ca_topic_score_codex":0.0015067173,"about_ca_topic_score_gemma":0.0029848432,"teacher_disagreement_score":0.0028022057,"about_ca_system_score_codex":0.0009816122,"about_ca_system_score_gemma":0.001786063,"threshold_uncertainty_score":0.009374261},"labels":[],"label_agreement":null},{"id":"W4401254207","doi":"10.1177/26330040241265449","title":"The use of art as a creative research method to understand psychosocial care needs for children with rare diseases","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Empathy and Medical Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation","keywords":"Psychosocial; Feeling; Reflexivity; Qualitative research; Psychology; Interpretative phenomenological analysis; Perception; Health care; Art therapy; Medicine; Clinical psychology; Developmental psychology; Psychotherapist; Medical education; Social psychology; Sociology; Social science","score_opus":0.07966007340017707,"score_gpt":0.46334414681953207,"score_spread":0.383684073419355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401254207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5760378,0.013904839,0.20188536,0.021162102,0.0015250299,0.011396153,0.0006990103,0.0002689646,0.1731207],"genre_scores_gemma":[0.82226825,0.0059925825,0.14721723,0.002216353,0.00023401644,0.013650857,0.00015366678,0.00015709801,0.008109951],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9459074,0.047483236,0.0009916149,0.0014352499,0.002985367,0.0011970651],"domain_scores_gemma":[0.9154776,0.07448232,0.0023617253,0.0044509456,0.0021011527,0.0011262273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047235504,0.0011700656,0.0010017,0.0067878487,0.009764916,0.014542103,0.0041974555,0.002705555,0.0053431853],"category_scores_gemma":[0.04000639,0.0010289595,0.0014096958,0.0044551105,0.032131307,0.009162083,0.014260743,0.0046659973,0.00060047116],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034322726,0.00005294485,0.0010256548,0.0008452551,0.000019196214,0.0008650844,0.94113874,0.00020924024,0.0006589794,0.024721,0.0013760282,0.029053444],"study_design_scores_gemma":[0.00007285368,0.00014760238,0.0019421822,0.0024772151,0.000044387976,0.0021135756,0.9017103,0.0006403092,0.00083701353,0.022079252,0.06787484,0.000060484625],"about_ca_topic_score_codex":0.0018728889,"about_ca_topic_score_gemma":0.00527764,"teacher_disagreement_score":0.047235504,"about_ca_system_score_codex":0.0064080125,"about_ca_system_score_gemma":0.007493586,"threshold_uncertainty_score":0.24980819},"labels":[],"label_agreement":null},{"id":"W4405479939","doi":"10.1177/26330040241304440","title":"Count Me In: patient-partnered research to address disparities for rare cancer patients","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Broad Institute","keywords":"Medicine; Cancer; Outreach; Breast cancer; Family medicine; Angiosarcoma; Translational research; Cancer registry; Internal medicine; Oncology; Pathology; Political science","score_opus":0.045764032968727754,"score_gpt":0.40002393887800114,"score_spread":0.35425990590927336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405479939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38608244,0.012521865,0.03468476,0.37669697,0.005460299,0.0098859845,0.019831985,0.0033826306,0.15145302],"genre_scores_gemma":[0.7989483,0.008415151,0.08740282,0.063468724,0.002628217,0.016087227,0.0077411383,0.000559314,0.014749044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97864383,0.01793938,0.00047468307,0.0007447503,0.0010017928,0.0011955834],"domain_scores_gemma":[0.93396664,0.025694417,0.0059532863,0.006597529,0.0039568227,0.02383127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027760854,0.00041573547,0.00045699932,0.0014198918,0.0028503337,0.0042244224,0.0017765252,0.0011359049,0.023480522],"category_scores_gemma":[0.055904716,0.00033545805,0.0009275728,0.0019332644,0.0013212928,0.0040735817,0.011931352,0.0020978516,0.0020871814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011839137,0.0010823148,0.0838972,0.0023120097,0.0002878886,0.00027610487,0.011936853,0.00043440465,0.0010114678,0.011787254,0.35154706,0.5342436],"study_design_scores_gemma":[0.002190041,0.0039532417,0.12453107,0.00552538,0.0004898351,0.00074796675,0.026446966,0.0024939335,0.002036566,0.034312174,0.79707575,0.00019702467],"about_ca_topic_score_codex":0.0031357403,"about_ca_topic_score_gemma":0.009282924,"teacher_disagreement_score":0.027760854,"about_ca_system_score_codex":0.0024931915,"about_ca_system_score_gemma":0.019629046,"threshold_uncertainty_score":0.14681518},"labels":[],"label_agreement":null},{"id":"W4409870204","doi":"10.1177/26330040251335660","title":"Access to drugs for rare diseases (DRD) in Canada: a comprehensive review of the provincial DRD-specific programs","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University","funders":"","keywords":"Government (linguistics); Medicine; Public administration; Political science","score_opus":0.2923756104496193,"score_gpt":0.4718568011154918,"score_spread":0.17948119066587248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409870204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02117622,0.92325425,0.0006965177,0.01733619,0.000600402,0.0008567829,0.010274368,0.00010732551,0.025697889],"genre_scores_gemma":[0.12282339,0.8657755,0.00312787,0.0028935159,0.000099794306,0.0003619165,0.002870077,0.000038164748,0.0020097336],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99172795,0.00095402956,0.0011194486,0.00035249544,0.0047616623,0.0010843985],"domain_scores_gemma":[0.93954307,0.013304392,0.0046304995,0.0007614149,0.036329318,0.005431314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009389228,0.00071227254,0.0012025423,0.01595567,0.005258577,0.0039822133,0.0026394527,0.000895669,0.0026694364],"category_scores_gemma":[0.030467002,0.00069748814,0.001279246,0.033161297,0.002226822,0.0012491726,0.001984913,0.0015958985,0.00021731535],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00034473895,0.00016929777,0.05495121,0.13954984,0.0007436103,0.0008344263,0.013470805,0.0021162075,0.0010527966,0.014048843,0.1142104,0.65850776],"study_design_scores_gemma":[0.00011904792,0.00014890489,0.256166,0.14261937,0.0017764932,0.0007177732,0.012177578,0.0009839995,0.0009019324,0.0009888475,0.58314896,0.00025102778],"about_ca_topic_score_codex":0.99482876,"about_ca_topic_score_gemma":0.9977329,"teacher_disagreement_score":0.8422165,"about_ca_system_score_codex":0.15778351,"about_ca_system_score_gemma":0.5530123,"threshold_uncertainty_score":0.97685176},"labels":[],"label_agreement":null},{"id":"W4413838869","doi":"10.1177/26330040251369887","title":"Addressing rare diseases and access to surgical care in Brazil: a call to action","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Call to action; Action (physics); Medicine; Medical emergency; Business; Intensive care medicine; Marketing","score_opus":0.017661642257106328,"score_gpt":0.37415735379459564,"score_spread":0.3564957115374893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413838869","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002658885,0.0151124755,0.00010247675,0.108672835,0.8752214,0.000011538204,0.000028165821,0.000031377847,0.00079328864],"genre_scores_gemma":[0.00032288875,0.010222095,0.00013662364,0.04177941,0.9450008,0.000015304675,0.000014287691,0.000019860952,0.0024886767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916025,0.001897124,0.0012829197,0.00081170566,0.0035917533,0.000814022],"domain_scores_gemma":[0.9400148,0.03235822,0.0030500554,0.0010151408,0.014937007,0.008624787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015936105,0.0032141095,0.0049112607,0.0036194252,0.003873744,0.011637397,0.0038927253,0.031807348,0.010367237],"category_scores_gemma":[0.041967202,0.0013248691,0.003697428,0.0015862263,0.003771613,0.008005739,0.0033900265,0.039812263,0.004799964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020617748,0.000012769904,0.000040817187,0.00039689106,0.000026251917,0.00018193564,0.000042402582,0.000024088919,0.00003797309,0.00064826966,0.99276876,0.005799246],"study_design_scores_gemma":[0.000075742115,0.00003017342,0.0003556183,0.0017090047,0.0001074823,0.00043523152,0.00020235669,0.00015730274,0.000048617872,0.0024610679,0.99437803,0.000039385253],"about_ca_topic_score_codex":0.005976391,"about_ca_topic_score_gemma":0.019721432,"teacher_disagreement_score":0.031807348,"about_ca_system_score_codex":0.0062146513,"about_ca_system_score_gemma":0.011279849,"threshold_uncertainty_score":0.08427918},"labels":[],"label_agreement":null},{"id":"W4414364561","doi":"10.1177/26330040251362885","title":"Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Rare Disease","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Plain language; Disease; Genetic enhancement; MEDLINE; Clinical trial","score_opus":0.01649032956457064,"score_gpt":0.31654796326965656,"score_spread":0.3000576337050859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414364561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007219585,0.9930057,0.000102571175,0.002206497,0.0028742924,0.000018530645,0.000102697246,0.000010996858,0.0016065089],"genre_scores_gemma":[0.0003447306,0.99411136,0.00023713728,0.002268921,0.001320562,0.000027977634,0.00012607388,0.000006414575,0.0015567741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996394,0.00007380923,0.00007975293,0.000045556404,0.00013334137,0.000028201308],"domain_scores_gemma":[0.99896705,0.00059030176,0.00013489879,0.000020332747,0.00022150538,0.000065890796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013955049,0.00079332985,0.0013194461,0.0015972295,0.00019475054,0.0012368537,0.000634839,0.0014486106,0.004423648],"category_scores_gemma":[0.0022920182,0.00021116412,0.00070650224,0.0014665402,0.00034702045,0.0010570745,0.00046381695,0.0025489938,0.0026977588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028591047,0.000059392354,0.00008683313,0.0271487,0.00013496955,0.00023309486,0.00005478179,0.00018894464,0.0013959529,0.0041679507,0.2766298,0.68961364],"study_design_scores_gemma":[0.000060784783,0.00011387597,0.00031190814,0.0067837266,0.00010886638,0.00040872188,0.000016002343,0.00002416798,0.00023649198,0.0005924455,0.99132967,0.000013346507],"about_ca_topic_score_codex":0.00088665064,"about_ca_topic_score_gemma":0.0014705831,"teacher_disagreement_score":0.004423648,"about_ca_system_score_codex":0.0008840953,"about_ca_system_score_gemma":0.001404344,"threshold_uncertainty_score":0.014798582},"labels":[],"label_agreement":null},{"id":"W7116944718","doi":"10.1177/26330040251404519","title":"From care to cure: a patient engagement framework for rare disease and orphan drug research","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Rare Disease","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University","funders":"","keywords":"Orphan drug; Rare disease; Patient care; Disease; Health care; Healthcare system; Patient participation","score_opus":0.018489323249504336,"score_gpt":0.3645214604750581,"score_spread":0.3460321372255538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116944718","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058579937,0.023268824,0.36892548,0.3849987,0.001645767,0.008448926,0.00088375143,0.000550397,0.15269826],"genre_scores_gemma":[0.65706635,0.009855392,0.30423254,0.015515225,0.00027393925,0.007967764,0.0006848355,0.00014772856,0.0042562527],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8471633,0.13761811,0.0033935392,0.0030239073,0.0045096646,0.004291352],"domain_scores_gemma":[0.9145308,0.06546864,0.0029056726,0.002462379,0.005931864,0.008700495],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1117525,0.0021069238,0.001173769,0.007859606,0.0175423,0.020465313,0.0064718085,0.008544512,0.0045253695],"category_scores_gemma":[0.057167508,0.0010334143,0.0037378022,0.0058823624,0.041701104,0.017312713,0.025505135,0.012076753,0.00080786645],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054775886,0.00021433235,0.0040452927,0.0031772226,0.00009372672,0.0008729233,0.26183578,0.0028467781,0.0002832165,0.65233487,0.012805504,0.06143568],"study_design_scores_gemma":[0.00012409523,0.00020106604,0.0015896223,0.0099999,0.00014130688,0.0009105275,0.25030407,0.0053231665,0.0003566075,0.4723841,0.2585159,0.0001495396],"about_ca_topic_score_codex":0.02598495,"about_ca_topic_score_gemma":0.0428618,"teacher_disagreement_score":0.8882475,"about_ca_system_score_codex":0.04704691,"about_ca_system_score_gemma":0.11018606,"threshold_uncertainty_score":0.5910108},"labels":[],"label_agreement":null}]}